Vera Therapeutics, Inc.

US$29.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VERAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR 10.56%
Div yield —
ROE (113.46%)
Biotechnology
Beta (5Y) 1.19
PE TTM —
TSR TTM 4.66%
Mkt cap US$2.153B
ROIC (60.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$31
4.14%
(86.80%)
Hold 3|7|5|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.36
0.39
0.39
0.43
6.07%
16.35%
11.06%
22.58%
Revenue$M
130.7
131.6
134.7
131.3
9.45%
4.02%
6.70%
(1.77%)
Peers (US$2.153B)
Cap (US$)
PE
2.187B
—
Capital
TTM
5Y
10Y
Leveragex
1.075
(0.227)
(0.191)
EBIT/Intx
6.486
0.110
0.084
Own earn%
64.56
(13.98)
10.63
Sh yield%
35.07
37.02
35.49
Owners
Insiders/Inst%
7.17
65.86
Short interest%
1.74
SBC / revenue%
2.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
11–16
$1 testx
0.0
Incr. ROIC%
2